Simultaneous Targeting of B-cell Malignancies and Human Immunodeficiency Virus with Bispecific Chimeric Antigen Receptor T Cells

Overview

Journal Haematologica

Specialty Hematology

Date 2024 May 23

PMID 38779743

Authors

Ryan Urak

Saghar Pahlavanneshan

Brenna Gittins

Ryotaro Nakamura

John A Zaia

John H Baird

Mary C Clark

Stephen J Forman

Xiuli Wang

Affiliations

Soon will be listed here.

References

Mehta S, Garg A, Gupta L, Mittal A, Khare A, Kuldeep C . Kaposi's sarcoma as a presenting manifestation of HIV. Indian J Sex Transm Dis AIDS. 2011; 32(2):108-10. PMC: 3195171. DOI: 10.4103/0253-7184.85415. View

Seif M, Kakoschke T, Ebel F, Bellet M, Trinks N, Renga G . CAR T cells targeting are effective at treating invasive pulmonary aspergillosis in preclinical models. Sci Transl Med. 2022; 14(664):eabh1209. DOI: 10.1126/scitranslmed.abh1209. View

Hill J, Seo S . How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies. Blood. 2020; 136(8):925-935. PMC: 7441168. DOI: 10.1182/blood.2019004000. View

Guan M, Lim L, Holguin L, Han T, Vyas V, Urak R . Pre-clinical data supporting immunotherapy for HIV using CMV-HIV-specific CAR T cells with CMV vaccine. Mol Ther Methods Clin Dev. 2022; 25:344-359. PMC: 9062763. DOI: 10.1016/j.omtm.2022.04.007. View

Baird J, Epstein D, Tamaresis J, Ehlinger Z, Spiegel J, Craig J . Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma. Blood Adv. 2021; 5(1):143-155. PMC: 7805341. DOI: 10.1182/bloodadvances.2020002732. View

Abramson J, Irwin K, Frigault M, Dietrich J, McGree B, Jordan J . Successful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphoma. Cancer. 2019; 125(21):3692-3698. DOI: 10.1002/cncr.32411. View

Huang J, Kang B, Ishida E, Zhou T, Griesman T, Sheng Z . Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth. Immunity. 2016; 45(5):1108-1121. PMC: 5770152. DOI: 10.1016/j.immuni.2016.10.027. View

Mohosho M . HIV prevalence in patients with cervical carcinoma: A cohort study at a secondary hospital in South Africa. Medicine (Baltimore). 2021; 100(35):e27030. PMC: 8415995. DOI: 10.1097/MD.0000000000027030. View

Zhou Y, Jadlowsky J, Baiduc C, Klattenhoff A, Chen Z, Bennett A . Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells. PLoS Pathog. 2023; 19(12):e1011853. PMC: 10773964. DOI: 10.1371/journal.ppat.1011853. View

10.

Wang X, Urak R, Walter M, Guan M, Han T, Vyas V . Large-scale manufacturing and characterization of CMV-CD19CAR T cells. J Immunother Cancer. 2022; 10(1). PMC: 8762141. DOI: 10.1136/jitc-2021-003461. View

11.

Munoz A, Urak R, Taus E, Hsieh H, Awuah D, Vyas V . Dexamethasone potentiates chimeric antigen receptor T cell persistence and function by enhancing IL-7Rα expression. Mol Ther. 2023; 32(2):527-539. PMC: 10861975. DOI: 10.1016/j.ymthe.2023.12.017. View

12.

Berhan A, Bayleyegn B, Getaneh Z . HIV/AIDS Associated Lymphoma: Review. Blood Lymphat Cancer. 2022; 12:31-45. PMC: 9063794. DOI: 10.2147/BLCTT.S361320. View

13.

Kumaresan P, Manuri P, Albert N, Maiti S, Singh H, Mi T . Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection. Proc Natl Acad Sci U S A. 2014; 111(29):10660-5. PMC: 4115509. DOI: 10.1073/pnas.1312789111. View

14.

Allred J, Bharucha K, Ozutemiz C, He F, Janakiram M, Maakaron J . Chimeric antigen receptor T-cell therapy for HIV-associated diffuse large B-cell lymphoma: case report and management recommendations. Bone Marrow Transplant. 2020; 56(3):679-682. PMC: 7956159. DOI: 10.1038/s41409-020-01018-7. View